MedTrace Logo

Directly Observed Therapy in HIV Infected Adolescent Focus Groups

NCT00079729 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2012-10-29

No results posted yet for this study

Summary

The purpose of this study is to help researchers use information from HIV infected adolescents to design a directly observed therapy (DOT) program that will help adolescents take their anti-HIV medications correctly.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Patricia Flynn, MD · St. Jude Children's Research Hospital

Eligibility

Min Age
16 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Completion
2004-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00079729 on ClinicalTrials.gov